Neil Kumar
CIK 1742485 · Chief Executive Officer · last filed 2026-06-08
Neil Kumar is a Chief Executive Officer who has filed 79 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $5.4M of BBIO on Jun 8, 2026. Across all open-market trades the lifetime net is −$73.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $306.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$306.06M
2
79
-$73.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Chief Executive Officer | 4,581,774 | $66.80 | $306.06M | -$145.07M | 76 | 2026-06-08 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Chief Executive Officer | 24,575,501 | — | — | $72.01M | 3 | 2019-07-08 |
Recent Filings
79 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | BBIO | Sell (S) | −80,000 | -$5.41M | EDGAR |
| 2026-05-26 | BBIO | Sell (S) | −26,103 | -$1.81M | EDGAR |
| 2026-05-19 | BBIO | Mixed | +34,979 | -$2.40M | EDGAR |
| 2026-05-11 | BBIO | Sell (S) | −80,000 | -$5.39M | EDGAR |
| 2026-04-13 | BBIO | Sell (S) | −80,000 | -$5.97M | EDGAR |
| 2026-03-19 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2026-03-16 | BBIO | Sell (S) | −80,000 | -$5.50M | EDGAR |
| 2026-02-23 | BBIO | Sell (S) | −28,053 | -$2.00M | EDGAR |
| 2026-02-18 | BBIO | Mixed | +33,728 | -$2.33M | EDGAR |
| 2026-02-12 | BBIO | Sell (S) | −80,000 | -$5.75M | EDGAR |